{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T18:19:14Z","timestamp":1784744354269,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002636","name":"Inje University","doi-asserted-by":"publisher","award":["20180109"],"award-info":[{"award-number":["20180109"]}],"id":[{"id":"10.13039\/501100002636","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Interpretation of mediastinal biopsy is often challenging even for experienced pathologists especially when a hematolymphoid neoplasm is suspected. Primary mediastinal large B-cell lymphoma (PMLBCL) and classic Hodgkin lymphoma (CHL) represent two major types of mature B-cell lymphomas of the mediastinum. Although PMLBCL and mediastinal CHL share many clinicopathologic characteristics, their treatment strategies and responses are remarkably different. We therefore aimed to find distinctive histologic or protein markers to better differentiate these two lesions.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Search for primary mediastinal B-cell lymphomas found 52 consecutive cases from 3 university hospitals of Korea during 2005 to 2012. Among them, 32 cases that were available for additional immunohistochemistry (IHC) assessment were enrolled in this study. These cases consisted of the following: CHL (<jats:italic>N<\/jats:italic>\u00a0=\u200913), PMLBCL (<jats:italic>N<\/jats:italic>\u00a0=\u200916), and B-cell lymphoma unclassifiable, with features intermediate between diffuse large B-cell lymphoma and CHL (gray zone lymphoma, <jats:italic>N<\/jats:italic>\u00a0=\u20093). Along with the clinicopathologic findings, the expression of p63, GATA3 and cyclin E was investigated by IHC in the three categorized lesions mentioned above.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Most clinical features overlapped between PMLBCL and CHL except for the increased disease progression and mortality found in PMLBCL. In the pathologic review, the presence of epithelioid granuloma favored a diagnosis of CHL, whereas reticulated or alveolar patterns of fibrosis were characteristic of PMLBCL. For protein markers, p63 was predominantly positive in PMLBCL (15\/16) compared with CHL (2\/13), which indicates that p63 is a marker of the highest diagnostic accuracy when calculated by the area under the ROC curve. GATA3 was expressed in the majority of CHL cases (10\/13) compared with PMLBCL (0\/16), while the expression of cyclin E was only rarely present in a minor population of PMLBCL.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>P63 expression in tumor cells, even focal expression, and no GATA3 is the most helpful feature in distinguishing PMLBCL from mediastinal CHL.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13000-019-0918-x","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T14:44:23Z","timestamp":1576507463000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma"],"prefix":"10.1186","volume":"14","author":[{"given":"Hyun-Jung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyeongsin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Kee","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jeong","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyekyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk Jin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Young","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Young","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,12]]},"reference":[{"key":"918_CR1","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1097\/JTO.0000000000000295","volume":"9","author":"BW Carter","year":"2014","unstructured":"Carter BW, Okumura M, Detterbeck FC, et al. Approaching the patient with an anterior mediastinal mass: a guide for radiologists. J Thorac Oncol. 2014;9:S110\u20138.","journal-title":"J Thorac Oncol"},{"key":"918_CR2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1097\/00000478-199607000-00012","volume":"20","author":"D Cazals-Hatem","year":"1996","unstructured":"Cazals-Hatem D, Lepage E, Brice P, et al. Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA (\"Groupe d'Etude des Lymphomes de l'Adulte\") study. Am J Surg Pathol. 1996;20:877\u201388.","journal-title":"Am J Surg Pathol"},{"key":"918_CR3","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","volume":"102","author":"KJ Savage","year":"2003","unstructured":"Savage KJ, Monti S, Kutok JL, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood. 2003;102:3871\u20139.","journal-title":"Blood."},{"key":"918_CR4","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1084\/jem.20031074","volume":"198","author":"A Rosenwald","year":"2003","unstructured":"Rosenwald A, Wright G, Leroy K, et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med. 2003;198:851\u201362.","journal-title":"J Exp Med"},{"key":"918_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1182\/blood-2014-05-575092","volume":"125","author":"K Dunleavy","year":"2015","unstructured":"Dunleavy K, Wilson WH. Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach? Blood. 2015;125:33\u20139.","journal-title":"Blood"},{"key":"918_CR6","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues, revised 4th ed: IARC Press Lyon; 2017."},{"key":"918_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v061.i08","volume":"61","author":"M Lopez-Raton","year":"2014","unstructured":"Lopez-Raton M, Cadarso-Suarez C, Rodriguez-Alvarez MX, et al. OptimalCutpoints: an R package for selecting optimal Cutpoints in diagnostic tests. J Stat Softw. 2014;61:1\u201336.","journal-title":"J Stat Softw"},{"key":"918_CR8","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1365-2559.2004.01969.x","volume":"45","author":"M Calaminici","year":"2004","unstructured":"Calaminici M, Piper K, Lee AM, et al. CD23 expression in mediastinal large B-cell lymphomas. Histopathology. 2004;45:619\u201324.","journal-title":"Histopathology"},{"key":"918_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s11899-012-0130-5","volume":"7","author":"K Dunleavy","year":"2012","unstructured":"Dunleavy K, Grant C, Eberle FC, et al. Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma? Curr Hematol Malig Rep. 2012;7:241\u20137.","journal-title":"Curr Hematol Malig Rep"},{"key":"918_CR10","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/ejh.13033","volume":"100","author":"Y Tanaka","year":"2018","unstructured":"Tanaka Y, Maeshima AM, Nomoto J, et al. Expression pattern of PD-L1 and PD-L2 in classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, and gray zone lymphoma. Eur J Haematol. 2018;100:511\u20137.","journal-title":"Eur J Haematol"},{"key":"918_CR11","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1038\/modpathol.2011.116","volume":"24","author":"FC Eberle","year":"2011","unstructured":"Eberle FC, Salaverria I, Steidl C, et al. Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations. Mod Pathol. 2011;24:1586\u201397.","journal-title":"Mod Pathol"},{"key":"918_CR12","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1182\/blood-2010-01-265827","volume":"116","author":"J Stanelle","year":"2010","unstructured":"Stanelle J, Doring C, Hansmann ML, et al. Mechanisms of aberrant GATA3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and reed\/Sternberg cells. Blood. 2010;116:4202\u201311.","journal-title":"Blood"},{"key":"918_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/bjh.15778","volume":"185","author":"C Lees","year":"2019","unstructured":"Lees C, Keane C, Gandhi MK, et al. Biology and therapy of primary mediastinal B-cell lymphoma: current status and future directions. Br J Haematol. 2019;185:25\u201341.","journal-title":"Br J Haematol"},{"key":"918_CR14","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1158\/1078-0432.CCR-05-2135","volume":"12","author":"A Tzankov","year":"2006","unstructured":"Tzankov A, Gschwendtner A, Augustin F, et al. Diffuse large B-cell lymphoma with overexpression of cyclin e substantiates poor standard treatment response and inferior outcome. Clin Cancer Res. 2006;12:2125\u201332.","journal-title":"Clin Cancer Res"},{"key":"918_CR15","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.humpath.2008.02.016","volume":"39","author":"G Gualco","year":"2008","unstructured":"Gualco G, Weiss LM, Bacchi CE. Expression of p63 in anaplastic large cell lymphoma but not in classical Hodgkin's lymphoma. Hum Pathol. 2008;39:1505\u201310.","journal-title":"Hum Pathol"},{"key":"918_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1365-2559.2009.03462.x","volume":"56","author":"S Hoeller","year":"2010","unstructured":"Hoeller S, Zihler D, Zlobec I, et al. BOB.1, CD79a and cyclin E are the most appropriate markers to discriminate classical Hodgkin's lymphoma from primary mediastinal large B-cell lymphoma. Histopathology. 2010;56:217\u201328.","journal-title":"Histopathology"},{"key":"918_CR17","doi-asserted-by":"crossref","first-page":"23157","DOI":"10.18632\/oncotarget.4319","volume":"6","author":"L Li","year":"2015","unstructured":"Li L, Xu-Monette ZY, Ok CY, et al. Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma. Oncotarget. 2015;6:23157\u201380.","journal-title":"Oncotarget"},{"key":"918_CR18","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1002\/1097-0142(19920515)69:10<2561::AID-CNCR2820691028>3.0.CO;2-6","volume":"69","author":"T Lavabre-Bertrand","year":"1992","unstructured":"Lavabre-Bertrand T, Donadio D, Fegueux N, et al. A study of 15 cases of primary mediastinal lymphoma of B-cell type. Cancer. 1992;69:2561\u20136.","journal-title":"Cancer."},{"key":"918_CR19","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.3109\/10428194.2011.596968","volume":"52","author":"H Go","year":"2011","unstructured":"Go H, Cho HJ, Paik JH, et al. Thymic extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a clinicopathological and genetic analysis of six cases. Leuk Lymphoma. 2011;52:2276\u201383.","journal-title":"Leuk Lymphoma"},{"key":"918_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1746-1596-6-60","volume":"6","author":"G Yu","year":"2011","unstructured":"Yu G, Kong L, Qu G, et al. Composite lymphoma in the anterior mediastinum: a case report and review of the literature. Diagn Pathol. 2011;6:60.","journal-title":"Diagn Pathol"},{"key":"918_CR21","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1177\/0218492315587817","volume":"23","author":"Z Chaari","year":"2015","unstructured":"Chaari Z, Charfi S, Hentati A, et al. Primary Burkitt lymphoma in the posterior mediastinum. Asian Cardiovasc Thorac Ann. 2015;23:1110\u20132.","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"918_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13256-016-1183-1","volume":"11","author":"M Cajozzo","year":"2017","unstructured":"Cajozzo M, Palumbo VD, Buscemi S, et al. Mediastinal syndrome from plasmablastic lymphoma in human immunodeficiency virus and human herpes virus 8 negative patient with polycythemia vera: a case report. J Med Case Rep. 2017;11:75.","journal-title":"J Med Case Rep"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-019-0918-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13000-019-0918-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-019-0918-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:31:50Z","timestamp":1607646710000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-019-0918-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["918"],"URL":"https:\/\/doi.org\/10.1186\/s13000-019-0918-x","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"11 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Our research was performed in accordance with the Declaration of Helsinki. This study was approved by the institutional review board of Sanggye Paik Hospital (SGPAIK2016\u201308-033).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare any financial support or relationship that may pose a conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"133"}}